Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OGSP Solution for Liver Function Assessment
NCT03457311Phase 3Unknown
- Start
- Sep 2013
- Primary completion
- Mar 2018
01
Overview
Phase 3, open-label, single-arm trial. Primary endpoint: Blood concentration of oral galactose at 60 minutes. Status: unknown.
Beyond the preview
Go deeper on NCT03457311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03457311.